Biophore India Pharmaceuticals Pvt. Ltd Walk In Interview 2022 MS/M.Sc(Science) in Any Specialization for API – R&D At Hyderabad/Secunderabad( Pashamailaram ) . Biophore India Pharmaceuticals Pvt. Ltd Notification full detailes below.Interested and eligible candidates can attend interview on scheduled time and venue.
- Vacancy details Advertisement
- Post Name: API – R&D
- Qualification: MS/M.Sc(Science) in Any Specialization
- Experienced: 0-7 Years
- Salary:₹ 50,000 – 3,00,000 P.A.
- Contact 9100033356 – Kavya
Job Description: Biophore India Pharmaceuticals Pvt. Ltd Hiring For API – R&D !
- Important Details :
- Location: Hyderabad/Secunderabad( Pashamailaram )
- Post of date: 26/3/2022
- Selection Process: The selection will be on the basis of Interview.
- Walk In Date:26th March 2022
- Walk In Time: 9.30 AM – 4.30 PM
- Venue:Time and Venue
15th April , 9.30 AM – 4.00 PM
Biophore India Pharmaceuticals Pvt Ltd. Plot# 231, IDA Phase -II, Pashamylaram, Biophore Road, Patancheru M, Sangareddy District. Telangana 502307
Contact – Kavya Reddy ( 9100033356 )
Hiring For Synthesis/Process API – R&D(0-7 Years) & MSc Freshers – Preferrably Male
Preferrable Male candidates
Location : Pashamailaram,, Patancheruvu
Freshers : 2020/2021/2022 – Passedouts
For Experienced Candidates : Only 1 Technical Round & HR Discussion. Need to submit one Original Document(10th/Inter Long Memo, BSc/MSc Original Degree or Provisional Certificate
Note for Freshers : We have bond for 3 Years, and need to submit one Original Document(10th/Inter Long Memo, BSc/MSc Original Degree or Provisional Certificate)
Interview Mode for Freshers :
1st Round : Written Test
2nd Round : Technical Discussion
Interested candidates can share profiles to [email protected] or
You can Contact 9100033356 – Kavya
Biophore, an established pharmaceutical company, is engaged in the development and manufacturing of niche pharmaceutical products for the generic industry. Within a decade since inception in 2007, Biophore has emerged as a trusted partner in the generic industry across US, Europe and other regulated markets.